3 analysts have expressed a variety of opinions on CG Oncology (NASDAQ:CGON) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table encapsulates ...

CG Oncology, Inc. (NASDAQ:CGON – Get Free Report)’s share price rose 7.3% during mid-day trading on Friday .The company traded as high as $26.68 and last traded at $27.85. Approximately 27,636 ...

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Tuesday, shares of CG Oncology Inc (Symbol: CGON) entered into oversold territory, hitting an RSI reading of ...

Shares of CG Oncology, Inc. (NASDAQ:CGON – Get Free Report) have earned an average recommendation of “Buy” from the nine research firms that are covering the firm, MarketBeat Ratings reports.

In this article, we are going to take a look at where CG Oncology, Inc. (NASDAQ:CGON) stands against the other oversold ...

CG Oncology (NASDAQ:CGON – Get Free Report)‘s stock had its “overweight” rating reissued by equities research analysts at ...

Handelsbanken Fonder AB purchased a new position in shares of CG Oncology, Inc. (NASDAQ:CGON – Free Report) in the fourth quarter, HoldingsChannel.com reports. The firm purchased 13,300 shares ...

CG Oncology, Inc. has a 12 month low of $24.16 and a 12 month high of $46.99. The company has a fifty day moving average price of $28.88 and a two-hundred day moving average price of $33.15. CG ...

IRVINE, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone ...

In this article, we are going to take a look at where CG Oncology, Inc. (NASDAQ:CGON) stands against the other oversold biotech stocks to buy now. Biotechnology stocks are among the most volatile ...

In this article, we are going to take a look at where CG Oncology, Inc. (NASDAQ:CGON) stands against other most oversold healthcare stocks to buy now. Healthcare costs and spending have been ...